The Indian equity market ended a three-week winning streak as Nifty50 slipped 2.6%, pressured by global trade tensions, H-1B visa concerns, and persistent foreign outflows. Time-based technical signals indicate potential intraday volatility, emphasizing cautious trading and disciplined risk management for short-term traders amid fluctuating support and resistance levels.Read More

Marcellus Investment Managers filed a police complaint against ex-CFO Pankaj Harish Gupta for diverting Rs 1.18 crore for personal use. The firm reassures clients their investments remain unaffected. Gupta admitted misappropriation, while Marcellus cooperates with authorities, emphasizing transparency, governance, and business continuity. Client assets are safeguarded.Read More

Co-working major WeWork India will launch its IPO on October 3. The issue size is estimated at Rs 3,000 crore. Bidding for anchor investors opens on October 1. The offering is entirely an Offer for Sale. Embassy Buildcon and WeWork Global will offload shares. WeWork India itself will not receive any proceeds.Read More

India’s public sector banks have achieved a remarkable turnaround, with asset quality improvements, disciplined cost management, and strong credit growth driving profitability. PSBs now deliver sustainable returns, with robust capital positions and cleaner balance sheets. SBI and PNB stand out as key beneficiaries, offering attractive investment potential in India’s evolving banking landscape.Read More

Silver prices in India have surged to record highs, outperforming gold with a 53% rise in 2025. Driven by industrial demand, festive buying, weakening rupee, and strong retail and ETF participation, silver benefits from supply deficits, technological applications, and investment appeal, signaling a potential long-term bullish trend in the bullion market.Read More

Precision components maker Indo MIM has filed preliminary papers with markets regulator Sebi to raise funds through an initial public offering (IPO) comprising a fresh issue of equity shares worth Rs 1,000 crore.Read More

Post ContentRead More

Sun Pharma faces potential impact from the US 100% tariff on patented drugs, which could reduce FY26–27 earnings by 8–10%. Generic drugs remain exempt. The company’s innovative portfolio, strong cash position, and mitigation options support steady revenue growth, maintaining HSBC’s Buy rating with Rs 1,850 target.Read More

Spirit maker Alcobrew Distilleries India Ltd has filed draft papers with capital markets regulator Sebi to seek its approval to raise funds through an initial public offering (IPO).Read More

The combined market valuation of the top-10 most valued firms eroded by Rs 2,99,661.36 crore last week, in line with a bearish trend in equities, with IT bellwether Tata Consultancy Services taking the biggest hit.Read More